Connection

Daniel Watterson to Humans

This is a "connection" page, showing publications Daniel Watterson has written about Humans.
Connection Strength

0.041
  1. Plugging the Leak in Dengue Shock. Adv Exp Med Biol. 2018; 1062:89-106.
    View in: PubMed
    Score: 0.006
  2. Fighting Ebola: A Window for Vaccine Re-evaluation? PLoS Pathog. 2017 01; 13(1):e1006037.
    View in: PubMed
    Score: 0.006
  3. No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing. Cell Rep. 2021 08 17; 36(7):109530.
    View in: PubMed
    Score: 0.002
  4. ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions. PLoS Pathog. 2021 07; 17(7):e1009723.
    View in: PubMed
    Score: 0.002
  5. A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses. Nat Commun. 2021 06 08; 12(1):3431.
    View in: PubMed
    Score: 0.002
  6. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 10; 21(10):1383-1394.
    View in: PubMed
    Score: 0.002
  7. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun. 2021 04 01; 12(1):2037.
    View in: PubMed
    Score: 0.002
  8. Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2. Environ Res. 2021 05; 196:110944.
    View in: PubMed
    Score: 0.002
  9. Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody. Sci Rep. 2021 02 08; 11(1):3318.
    View in: PubMed
    Score: 0.002
  10. Rapid Response Subunit Vaccine Design in the Absence of Structural Information. Front Immunol. 2020; 11:592370.
    View in: PubMed
    Score: 0.002
  11. Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion. J Gen Virol. 2021 01; 102(1).
    View in: PubMed
    Score: 0.002
  12. Basimarols A, B, and C, Highly Oxygenated Pimarane Diterpenoids from Basilicum polystachyon. J Nat Prod. 2019 10 25; 82(10):2828-2834.
    View in: PubMed
    Score: 0.002
  13. Stachyonic Acid: A Dengue Virus Inhibitor from Basilicum polystachyon. Chemistry. 2019 Apr 17; 25(22):5664-5667.
    View in: PubMed
    Score: 0.002
  14. New genotypes of Liao ning virus (LNV) in Australia exhibit an insect-specific phenotype. J Gen Virol. 2018 04; 99(4):596-609.
    View in: PubMed
    Score: 0.002
  15. Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection. J Virol. 2018 02 15; 92(4).
    View in: PubMed
    Score: 0.002
  16. The Heptad Repeat C Domain of the Respiratory Syncytial Virus Fusion Protein Plays a Key Role in Membrane Fusion. J Virol. 2018 02 15; 92(4).
    View in: PubMed
    Score: 0.002
  17. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope. Structure. 2018 01 02; 26(1):51-59.e4.
    View in: PubMed
    Score: 0.001
  18. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light. Transfusion. 2017 11; 57(11):2677-2682.
    View in: PubMed
    Score: 0.001
  19. Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6. Immunol Cell Biol. 2017 05; 95(5):491-495.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.